Gemilukast

N/A

Report date: 2024/12/12 09:37:33
NME

Base Information

Drug NameGemilukast
Drug Alias Name吉鲁司特gemilukastumgemilukastONO-6950
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCysteinyl Leukotriene Receptor 2 antagonists
TargetsCysteinyl Leukotriene Receptor 2
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOno Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksN/A